We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Children in El Salvador Tested for Lead Poisoning

By Labmedica staff writers
Posted on 30 Apr 2008
Children in Regalo de Dios, a small urban community of 240 families in the city of Soyapango, El Salvador, were tested for lead poisoning and anemia. More...


The LeadCare II system makes lead testing easy, delivering quantitative blood-lead results with only two drops of blood in just three minutes. Far simpler to administer than traditional blood-lead tests, the device can be used with capillary or venous sample, can be combined with other routine waived blood tests, and saves administrative time spent on paper work, tracking, and follow-up.

Regular blood-lead screening tests are important for young children because elevated lead levels are connected to a host of learning and social problems--from reading difficulties and attention deficient hyperactivity disorder (ADHD) to increased risk of violence and drop-outs. Recent studies even suggest that some of the mental decline associated with aging--for example, losses in verbal and visual memory and language ability--may relate to lead exposure earlier in life.

To help assess the problem of lead poisoning among Salvadoran children, ESA Biosciences (Chelmsford, MA, USA), a Magellan Biosciences company and manufacturer of systems to test for lead poisoning in children, donated its LeadCare system test kits to the University of Washington (Seattle, WA, USA) for use in its Children's Health International Medicine Project of Seattle (CHIMPS).

According to Dr. Erica Freeman, a pediatric resident at the University of Washington and one of the project leaders, "The CHIMPS team tested 55 children [in September 2007], ages one to five years, for blood-lead levels, hemoglobin, and zinc potassium phosphate hexahydrate (ZPPH)--a sensitive diagnostic indicator for iron deficiency anemia. In most cases, we were able to perform all three tests using capillary blood samples drawn from a single lancet puncture. Six children, or 11% of those tested, had elevated lead levels greater than 10 µg/dl (ranging from 10.5-20.2 µg/dl). For families of children with elevated lead levels, we provided additional counseling around decreasing environmental lead exposure, and in one case, we also made a home visit.”

More than 100 community members attended the health education events held in the community center at the end of the week of testing. ESA donated additional LeadCare reagent kits for use at the Benjamin Bloom Children's Hospital in San Salvador (San Salvador, El Salvador), one of only two tertiary care centers for children in Central America.

Dr. Freeman added, "A team member returned to Regalo de Dios in January [2008] to perform follow-up testing on the children identified with elevated blood-lead levels the previous September. All of their levels had dropped to less than 10 µg/dl, below the toxic threshold, according to World Health Organization (WHO; Geneva, Switzerland) guidelines.

CHIMPS presented the project results at the Academic Pediatric Association Conference held in March 2008 in Los Angeles (CA, USA).


Related Links:
ESA Biosciences
University of Washington
World Health Organization

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Slide Scanner System
NanoZoomer S540MD
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.